Vepdegestrant significantly improved outcomes for certain patients with ER-positive, HER2-negative advanced breast cancer ...

Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...

Among patients with ESR1-mutant, ER+, HER2– advanced breast cancer, vepdegestrant improved survival without progression when ...

This year’s report provides the external sector assessment of 30 of the world’s largest economies on the basis of their 2023 data. With tight monetary policy conditions in key advanced economies ...

After months of planning and roster building, the Swift Current 57's have their WCBL home opener tonight at Mitchell Field.

Estrella Immunopharma, Inc. (NASDAQ:ESLA) has announced a major milestone in its STARLIGHT-1 Phase I/II clinical trial, ...

Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical stage biopharmaceutical company ...

Nagpur: Maharashtra Metro Rail Corporation Limited (MahaMetro) is aiming to complete the Lok Vihar Metro Station by November ...

Patients with HR-positive, HER2-negative metastatic breast cancer should be consistently tested for ESR1 mutations to inform next lines of therapy.

Procalcitonin levels greater than 0.9 ng/mL may be a useful biomarker for identifying bacterial infections among febrile patients with JSLE.

Matthew Martin was officially introduced during the Kyrene Governing Board meeting last week as the new principal of Kyrene ...